| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 09/20/2000 | EP0696288B1 Quinoxalindione derivatives, their preparation and their use in drugs |
| 09/20/2000 | CN1056609C Benzoyl guanidines, their production and their use in medicinal compositions |
| 09/19/2000 | US6120696 Proton conductors in liquid form |
| 09/14/2000 | WO2000053547A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
| 09/14/2000 | DE19910370A1 Verfahren zur Herstellung von Tensidalkoholen und Tensidalkoholethern, die hergestellten Produkte und ihre Verwendung A process for the preparation of surfactant alcohols and surfactant alcohol ethers, the manufactured products and their use |
| 09/13/2000 | EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP0799208B1 Pyridine and pyrazinedicarboxylic-acid derivatives as cell proliferation regulators |
| 09/13/2000 | CN1266431A Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 09/12/2000 | US6117940 Solid phase synthesis of compounds such as the imidazoles, benzodiazepines, pyrazines, and steroid mimics. |
| 09/08/2000 | WO2000052001A1 Piperazine derivatives and process for the preparation thereof |
| 09/06/2000 | EP1033362A1 Crystals of s,s]-ethylenediamine-n,n'-disuccinic acid with high bulk density and method of obtaining the same |
| 09/06/2000 | EP0824514B1 Dihalopropene compounds, insecticides containing them as active ingredients, and intermediates for their production |
| 09/06/2000 | CN1265654A 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring |
| 09/06/2000 | CN1265645A Urokinase inhibitors |
| 09/06/2000 | CN1056141C 哌嗪衍生物 Piperazine derivatives |
| 09/05/2000 | US6114526 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 09/05/2000 | US6114524 Process for producing halogenated heteroaryl compounds |
| 09/05/2000 | US6114332 Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agents |
| 08/31/2000 | WO2000001375A3 Calcium channel blockers |
| 08/31/2000 | DE19907829A1 Verfahren zur Herstellung von cis-2,6-Dimethylpiperazin A process for preparing cis-2,6-dimethylpiperazine |
| 08/30/2000 | EP1031568A1 Process for the preparation of cis-Dimethylpiperazine |
| 08/30/2000 | CN1265010A Dehydration plant |
| 08/29/2000 | US6111106 1,4,5,6-tetrahydropyrazine-2-carboxamides |
| 08/29/2000 | US6110946 An enzyme inhibitors of retroviral aspartate protease for the treatment of aids |
| 08/29/2000 | US6110933 Amino acid derivatives and their use as phospholipase A2 inhibitor |
| 08/29/2000 | US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 08/29/2000 | US6110911 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 08/24/2000 | WO2000031051B1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors |
| 08/23/2000 | EP1030212A2 Electrochromic device with improved lightfastness |
| 08/23/2000 | EP1029909A1 Organic electroluminescence device and phenylenediamine derivative |
| 08/23/2000 | EP1028942A2 Dipeptide nitriles |
| 08/23/2000 | EP1028729A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/23/2000 | CN1264371A Pyrazine derivatives, their preparation and medicines containing them |
| 08/23/2000 | CN1264370A Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them |
| 08/23/2000 | CN1264369A Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them |
| 08/23/2000 | CN1264368A Polyhydroxybutylpyrazines, their preparation and medicines containing them |
| 08/23/2000 | CN1264300A Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
| 08/22/2000 | US6107274 Enzyme inhibitors as hypoglycemic agents in treatment of type-ii diabetes |
| 08/22/2000 | CA2187409C Stable crystalline tetrahydrofolic acid salts |
| 08/18/2000 | CA2298800A1 Electrochromic device having improved light stability |
| 08/16/2000 | EP1028111A1 Amide derivatives or salts thereof |
| 08/16/2000 | EP1027713A1 Nonaqueous electrolyte for electrical storage devices |
| 08/16/2000 | EP1027397A1 Electrochrome polymer systems |
| 08/16/2000 | EP1026950A1 Treatment of schizophrenia with ampakines and neuroleptics |
| 08/16/2000 | EP0877612B1 Use of piperazine derivatives for the treatment of cognitive disorders |
| 08/16/2000 | EP0738259B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them |
| 08/16/2000 | CN1055468C Alkylaminoindane compounds process for preparing them and pharmaceutical compositions containing them,and use |
| 08/15/2000 | US6103724 Exhibit mainly antipsychotic effects, e.g., schizophrenia, organic mental disorders, affective disorders, anxiety, personality disorders; neuroleptic activitiy; atypical antipsychotics, cognition activators, antidepressants; |
| 08/15/2000 | US6103720 Ketobenzamides as calpain inhibitors |
| 08/15/2000 | US6103658 Olefin polymerization catalysts containing group 8-10 transition metals, processes employing such catalysts and polymers obtained therefrom |
| 08/15/2000 | CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid |
| 08/10/2000 | WO2000046184A1 N2-phenylamidine derivatives |
| 08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
| 08/09/2000 | EP1026151A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides |
| 08/09/2000 | EP1026142A1 2,3-difluorophenyl derivatives having negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element |
| 08/09/2000 | EP1025102A1 Bicyclic kinase inhibitors |
| 08/09/2000 | EP1025097A1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d 4? receptor subtype ligands |
| 08/09/2000 | EP0623132B1 Disubstituted polycyclic systems as cognition enhancers |
| 08/09/2000 | CN1262684A 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 08/09/2000 | CN1262675A (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
| 08/09/2000 | CN1262620A Beta-Alkoxyacrylates against malaria |
| 08/09/2000 | CN1262269A Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide |
| 08/08/2000 | US6100400 Process for the preparation of esters of [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]-ethoxy]acetic acid |
| 08/08/2000 | US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents |
| 08/08/2000 | US6100263 Controlling animal pests or harmful fungi; 2-methoxyimino-2-(2'-(1?-methyl,1?-(1?'-(6??-(4??'-chlorophenyl) -hexyloxyimino) ,2?',2?'-dimethylpropyl))iminooxymethyl)-phenylacetic acid monomethylamide, for example |
| 08/08/2000 | CA2187402C Quinoxaline derivatives for treating tinnitus |
| 08/03/2000 | WO2000044731A1 Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors |
| 08/03/2000 | WO2000044729A1 Crystalline quinoxaline derivative |
| 08/03/2000 | WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 08/03/2000 | WO2000044382A1 Composition and method for treating diabetes |
| 08/03/2000 | WO2000006146A9 Substituted anilide compounds and methods |
| 08/03/2000 | CA2360687A1 Composition and method for treating diabetes |
| 08/03/2000 | CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 08/02/2000 | EP1023282A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 08/02/2000 | EP1023278A1 Process for preparing substituted pyrazine compounds |
| 08/02/2000 | EP0708759B1 Method for preparing substituted pyrazines |
| 08/01/2000 | US6096768 Administering a 3, 5, 6-substituted phenyl compound for the treatment of inflammation and autoimmune disorders |
| 08/01/2000 | US6096744 Sulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 08/01/2000 | US6096743 1,2,3,4-tetrahydroquinoxalinedione derivative |
| 08/01/2000 | CA2178760C Hiv protease inhibitors |
| 08/01/2000 | CA2015034C Piperazine derivatives |
| 07/27/2000 | WO2000043356A1 Novel cationic couplers and their use for oxidation dyeing |
| 07/27/2000 | WO2000042979A1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods |
| 07/27/2000 | WO2000012500A3 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | WO1999057098A3 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2323710A1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods |
| 07/27/2000 | CA2323708A1 Novel cationic couplers and their use for oxidation dyeing |
| 07/26/2000 | EP1021439A1 Crystalline antifungal polymorph |
| 07/26/2000 | EP1021412A1 Nitration of aromatic compounds |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP0556393B1 Fused pyrazine derivative |
| 07/26/2000 | CN1261358A Angiogenesis inhiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 07/26/2000 | CN1261354A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261353A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261352A New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists |
| 07/26/2000 | CN1054849C Process for producing quaternary glycine nitriles |
| 07/25/2000 | US6093823 By continuous racemate splitting via diastereomeric salt pairs with re-racemisation of the residual amino acid or amino acid derivative in the mother liquid with the aid of an optically active acid |